References
- Pherm. Ther. v.37 N. E. Sladek
- J. Med. Chem. v.34 R. F. Borch;R. R. Valente
- J. Am. Chem. Soc. v.92 H. C. Brown;W. C. Dickason
- Tetrahedron v.35 D. C. Wigfield
- J. Am. Chem. Soc. v.98 W. T. Wipke;P. Gund
- J. Org. Chem. v.33 E. M. Kaiser;C. R. Hauser
- J. Am. Chem. Soc. v.73 L. H. Amundsen;L. S. Nelson
- J. Am. Chem. Soc. v.107 W. N. Setzer;A. E. Sopchik;W. G. Bentrude
- J. Med. Chem. v.23 V. L. Boyd;G. Zon;V. L. Himenes;J. K. Stalick;A. D. Mighell;H. V. Secor
- Korean J. Med. Chem. v.2 J. C. Kim;Y. H. Lee
Cited by
- Preparation of N'-Substituted Anilino-N-Methyl-N-Nitorsoureas as Candidate Antitumor Agents vol.17, pp.6, 1993, https://doi.org/10.1007/bf02979118
-
Synthesis and antitumor evaluation of
$\alphamethylene-\gamma-butyrolactone-linked$ to 5-substituted uracil nucleic acid bases vol.19, pp.3, 1996, https://doi.org/10.1007/bf02976897 - Potential Antitumor ${\alpha}$-methylene-${\gamma}$-butyrolactone-bearing nucleic acid bases. 2. synthesis of $5^I-Methyl-5^I$-[2-(5-substituted uracil-1-yl)ethyl]-$2^I-oxo-3^I$-methylenetetrahydrofur vol.20, pp.3, 1993, https://doi.org/10.1007/bf02976153
- Potential Antitumor $\alpha$-Methylene-$\gamma$-butyrolactone-Bearing Nucleic Acid Base. 3. Synthesis of $5^1$-Methyl-$5^1$-[(6-substituted-9H-purin-9-yl)methyl]-$2^1$-oxo-$3^1$-methylenetetrahydrofur vol.21, pp.4, 1993, https://doi.org/10.1007/bf02974643